<!doctype html>

<html lang="en">
<head>
    <meta charset="utf-8">
    <meta content="IE=edge" http-equiv="X-UA-Compatible">
<!--    <meta content="width=device-width, initial-scale=1.0" name="viewport">-->
    <title>GA TB Reference Guide</title>
    <meta content="GA TB Reference Guide" name="description">
    <meta content="SitePoint" name="author">
    <link href="../assets/uikit.css" rel="stylesheet">
    <link href="../assets/style.css" rel="stylesheet">
</head>

<body>

<div class="uk-container">
    <p> <span class="view-in-chapter-highlight"> View in chapter → <span> <a href="3_treatment_of_latent_tb_infection_(ltbi)__a__treatment_regimens.html#table5"> Treatment Regimens for LTBI </a></p>
    <p class="last-updated"><i>Last Updated June 2024</i></p>
    <hr>
     <div class="uk-overflow-auto" id="table_5_dosages_for_recommended_lbti_treatment_regimens">
        <div class="uk-tabs-container">
            <ul class="tabs">
                <li><button class="tab active-tab" onclick="switchTab(0, event)">Isoniazid* and rifapentine&dagger;</button></li>
                <li><button class="tab" onclick="switchTab(1, event)">Rifampin&para;</button></li>
                <li><button class="tab" onclick="switchTab(2, event)">Isoniazid* and rifampin&para;</button></li>
                <li><button class="tab" onclick="switchTab(3, event)">Isoniazid*</button></li>
            </ul>
        </div>

        <table id="tab-content0" class="uk-table uk-table-small tab-content active-tab">
            <tbody>
                <tr>
                    <th>Duration</th>
                    <td>3 months</td>
                </tr>
                <tr>
                    <th>Dosage And Age Group</th>
                    <td>
                        <strong class="highlight">Adults and children aged &gt; 12 yrs</strong><br>
                        <strong>Isoniazid:</strong><br>
                        15 mg/kg rounded up to the nearest 50 or 100 mg; 900 mg maximum<br>
                        <strong>Rifapentine:</strong><br>
                        10 - 14.0 kg, 300 mg<br>
                        14.1 - 25.0 kg, 450 mg<br>
                        25. 1 - 32.0 kg, 600 mg<br>
                        32.1 - 49.9 kg, 750 mg<br>
                        &gt; 50.0 kg, 900 mg maximum&nbsp;<br>
                        <br>
                        <strong class="highlight">Children aged 2 - 11 yrs</strong><br>
                        <strong>Isoniazid*</strong>: <br> 25 mg/kg; 900 mg maximum<br>
                        <strong>Rifapentine&dagger;</strong>: <br>
                        see above&nbsp;<br>
                    </td>
                </tr>
                <tr>
                    <th>Frequency</th>
                    <td>Once weekly</td>
                </tr>
                <tr>
                    <th>Total doses</th>
                    <td>12</td>
                </tr>
            </tbody>
        </table>

        <table id="tab-content1" class="uk-table uk-table-small tab-content">
            <tbody>
                <tr>
                    <th>Duration</th>
                    <td>4 months</td>
                </tr>
                <tr>
                    <th>Dosage And Age Group</th>
                    <td>
                        <strong>Adults</strong>: 10 mg/kg<br>
                        <strong>Children</strong>: 15 - 20 mg/kg**<br>
                        <strong>Maximum dose</strong>: 600 mg<br>
                    </td>
                </tr>
                <tr>
                    <th>Frequency</th>
                    <td>Daily</td>
                </tr>
                <tr>
                    <th>Total doses</th>
                    <td>120</td>
                </tr>
            </tbody>
        </table>

        <table id="tab-content2" class="uk-table uk-table-small tab-content">
            <tbody>
                <tr>
                    <th>Duration</th>
                    <td>3 months</td>
                </tr>
                <tr>
                    <th>Dosage And Age Group</th>
                    <td>
                        <strong class="highlight">Adults </strong> <br>
                        <strong>Isoniazid*</strong>: <br> 5 mg/kg; 300 mg maximum <br>
                        <strong>Rifampin&para;</strong>: <br> 10 mg/kg; 600 mg maximum <br><br>
                        <strong class="highlight">Children</strong>: <br>
                        <strong>Isoniazid*</strong>: <br> 10 - 20 mg/kg&dagger;&dagger; ; 300 mg maximum <br>
                        <strong>Rifampin&para;</strong>: <br> 15 - 20 mg/kg; 600 mg maximum <br>
                    </td>
                </tr>
                <tr>
                    <th>Frequency</th>
                    <td>Daily</td>
                </tr>
                <tr>
                    <th>Total doses</th>
                    <td>90</td>
                </tr>
            </tbody>
        </table>

        <table id="tab-content3" class="uk-table uk-table-small tab-content">
            <tbody>
                <tr>
                    <th>Duration</th>
                    <td>9 months</td>
                    <td>6 months</td>
                </tr>
                <tr>
                    <th>Dosage And Age Group</th>
                    <td>
                        <strong>Adults</strong>: <br> 5 mg/kg <br>
                        <strong>Children</strong>: <br> 10 - 20 mg/kg&dagger;&dagger; <br>
                        <strong>Maximum dose</strong>: <br> 300 mg <br>
                    </td>
                    <td>
                        <strong>Adults</strong>: <br> 5 mg/kg <br>
                        <strong>Children</strong>: <br> 10 - 20 mg/kg&dagger;&dagger; <br>
                        <strong>Maximum dose</strong>: <br> 300 mg <br>
                    </td>
                </tr>
                <tr>
                    <th>Frequency</th>
                    <td>Daily</td>
                    <td>Daily</td>
                </tr>
                <tr>
                    <th>Total doses</th>
                    <td>270</td>
                    <td>180</td>
                </tr>
            </tbody>
        </table>
    </div>

    <p>
        * Isoniazid is formulated as 100-mg and 300-mg tablets. † Rifapentine is formulated as 150-mg tablets in blister packs that should be kept sealed until use. Rifapentine should not be used for children &lt2 years of age due to lack of pharmacokinetic data.¶ Rifampin (rifampicin) is formulated as 150-mg and 300-mg capsules.   ** The American Academy of Pediatrics acknowledges that some experts use rifampin at 20 - 30 mg/kg for the daily regimen when prescribing for infants and toddlers. (Source: American Academy of Pediatrics. Tuberculosis. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2018 Report of the Committee on Infectious Diseases. 31st ed. Itasca, IL: American Academy of Pediatrics; 2018:829-53). †† The American Academy of Pediatrics recommends an isoniazid dosage of 10 - 15 mg/kg for the daily regimen. Adapted from MMWR Recomm Rep 2020; 69(1):1-11.
    </p>
</div>
</body>
       
<script src="../assets/uikit.js" type="text/javascript"></script>
<script src="../assets/uikit-icons.js" type="text/javascript"></script>
<script src="main.js" type="text/javascript"></script>
</html>
